Evidence map›Paper›PMID 40778837›Full record

ArticleMicrobiology spectrum2025

Rapid screening for carbapenemase-producing carbapenem-resistant

Camila Loredana P A M Bezerra, Barbara de Almeida Lessa Castro, Anna Sara Levin, Lindissy Luara Baldi, Ana Paula Cury, Flavia Rossi, Natashia Reese, Fernanda C Lessa, Susan Bollinger, Matias Chiarastelli Salomão and 1 more

Abstract read
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Camila Loredana P A M BezerraDepartment of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.ORCID 0009-0001-1349-2206
Barbara de Almeida Lessa CastroDepartment of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Anna Sara LevinDepartment of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
Lindissy Luara BaldiMicrobiology Laboratory, Central Laboratory Division, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
Ana Paula CuryMicrobiology Laboratory, Central Laboratory Division, Hospital das Clínicas, University of São Paulo, São Paulo, Brazil.
Flavia RossiLaboratório de Medicina Laboratorial (LIM-03), Departamento de Patologia, Faculdade de Medicina FMUSP, Universidade de São Paulo, São Paulo, Brazil.
Natashia ReeseDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Fernanda C LessaDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Susan BollingerDivision of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Matias Chiarastelli SalomãoDepartment of Infectious Diseases, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.ORCID 0000-0001-5507-0063
Rapid ICT Screening Group

Funding

CDC HHS SBA-22-SBA-032Fundação de Amparo à Pesquisa do Estado de São Paulo 2024/07836-1
6 · The paper itself

Abstract

Carbapenemase-producing carbapenem-resistant

Indexed as

Bacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeChromatography, AffinityEnterobacteriaceae InfectionsRectumAnti-Bacterial AgentsCarbapenemsHumansSensitivity and SpecificityAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemscarbapenemasecarbapenem-resistant Enterobacteralesclinical validationcolonization screeningfecal carriersimmunochromatographic testintestinal colonizationO.K.N.V.I. RESIST-5 ICTrapid testrectal swab

Identifiers

PMID40778837
PMCPMC12419764

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.